Table 1.

Demographics and clinical features.

	All RA (N = 166)	Without CAC (N = 79)	With CAC (N = 82)	P value
Age, years	54 [45, 63]	48 [40, 54]	60 [54, 69]	< 0.001
Sex, # female	114 (69)	64 (81)	47 (57)	0.001
Race, # Caucasian	150 (88)	68 (86)	75 (91)	0.28
DAS28-ESR, score	3.88 [2.64,3.4.84]	3.46 [2.39, 4.40]	4.05 [2.84, 5.01]	0.04
Rheumatoid factor, # positive	114 (72)	52 (69)	58 (72)	0.66
hs-CRP, mg/dl	4.0 [1.2, 11]	3.00 [1.00, 9.50]	5.00 [2.00, 12.50]	0.09
Waist/hip ratio, units	0.88 [0.81, 0.95]	0.84 [0.78, 0.92]	0.91 [0.83, 0.99]	< 0.001
Body Mass Index, kg/m2	28.3 [24.0, 33.1]	28.30 [24.02, 33.51]	28.34 [23.71, 31.53]	0.34
Systolic BP, mmHg	133 [118, 146]	129 [116, 139]	137 [121, 151]	0.004
Diastolic BP, mmHg	75 [67, 82]	73 [67, 80]	76 [69, 85]	0.13
Current smoker, # yes	40 (24)	17 (22)	22 (27)	0.44
Total cholesterol, mg/dL	184 [156, 210]	183 [157, 204]	188 [154, 214]	0.70
LDL-cholesterol, mg/dL	111 [88, 134]	105 [89, 134]	115 [90, 136]	0.44
HDL-cholesterol, mg/dL	43 [37, 54]	44 [38, 55]	43 [36, 53]	0.32
Triglycerides, mg/dL	111 [80, 158]	108 [81, 149]	112 [80, 164]	0.58
CAC score, Agatston units	2.70 [0.00, 150.30]	0.00 [0.00, 0.00]	148.80 [40.80, 470.30]	< 0.001
Statins, # user	21 (12)	6 (7)	15 (18)	0.04
NSAIDs, # user	54 (33)	29 (37)	25 (30)	0.40
Corticosteroid, # user	89 (54)	42 (53)	45 (55)	0.83
Methotrexate, # user	118 (72)	61 (77)	54 (66)	0.11
Hydroxychloroquine, # user	42 (25)	23 (29)	17 (21)	0.22
Leflunomide, # user	29 (18)	13 (16)	16 (20)	0.61
Anti-TNFα, # user	33 (20)	17 (22)	14 (17)	0.47